Management of solid tumours in organ-transplant recipients

Lancet Oncol. 2007 Oct;8(10):921-32. doi: 10.1016/S1470-2045(07)70315-7.


Malignancy is a well-recognised complication of transplantation and can occur de novo, as a recurrence of a pre-existing malignancy, or from transmission of malignancy from the donor. Common de-novo malignancies are those of the skin and the lymphoreticular system. Various solid-organ cancers have also been reported in transplant recipients and each poses a unique management challenge in view of the unusual setting. We review solid-organ cancers in transplant recipients and their management, including surveillance and prevention.

Publication types

  • Review

MeSH terms

  • Humans
  • Immune Tolerance
  • Incidence
  • Neoplasm Recurrence, Local
  • Neoplasms / epidemiology
  • Neoplasms / etiology
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Organ Transplantation / adverse effects*
  • Tissue Donors